Pro/Ala/Ser (PAS) peptides as an alternative to polyethylene glycol (PEG) for the surface shielding of lipid nanoparticles (LNPs) carrying therapeutic mRNA
This study demonstrates that Pro/Ala/Ser (PAS) peptides can effectively replace polyethylene glycol (PEG) as a surface-shielding component in lipid nanoparticles for mRNA delivery, achieving comparable physicochemical properties and transfection efficiency while offering a biodegradable alternative that avoids anti-PEG immune responses.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Imagine a tiny delivery truck, no larger than a speck of dust, designed to carry a fragile instruction manual into the heart of a human cell. This is the lipid nanoparticle, a microscopic vessel that has revolutionized modern medicine by allowing doctors to deliver genetic messages, such as those found in mRNA vaccines, directly to where they are needed. To work, these trucks must be coated with a protective layer, much like a shield, to keep them stable in the bloodstream and prevent the body's immune system from attacking them too quickly. For years, scientists have relied on a synthetic plastic-like substance called polyethylene glycol, or PEG, to create this shield. It is effective, but it has a hidden flaw: because it is a foreign chemical that the body cannot break down, it can sometimes trigger allergic reactions or cause the immune system to clear the medication out of the body before it can do its job. As more people are exposed to PEG through everyday products like cosmetics and processed foods, the risk of these reactions grows, prompting researchers to search for a safer, more natural alternative.
In a recent study, a team of scientists from the Technical University of Munich and XL-protein GmbH explored a biological substitute for this synthetic shield. Instead of using the plastic-like PEG, they turned to a chain of natural building blocks found in the human body: a specific sequence of three amino acids called proline, alanine, and serine. They refer to this chain as a PAS peptide. Unlike the synthetic polymer, this natural chain is biodegradable, meaning the body can easily break it down and remove it without leaving a trace. The researchers wanted to see if they could swap the synthetic PEG coating on their lipid nanoparticle trucks for this natural PAS coating and still achieve the same high-quality delivery of genetic instructions.
To test this idea, the team first had to build the delivery trucks themselves. They created a new type of lipid molecule where the PEG tail was replaced by a chain of forty of these natural amino acids, capped with a protective group to keep it neutral. They then mixed this new lipid with other standard ingredients to form nanoparticles, following the exact same recipe used for established, approved medications. The cargo they chose to test was a set of instructions for making a specific protein, a modified version of a mouse interferon, which is a type of immune signaling molecule. They also included a small tag on the protein, like a name badge, so they could easily track it later.
The researchers then introduced these new trucks into human liver cells grown in a laboratory dish. They wanted to see if the cells could read the instructions inside the truck and produce the protein. The results were encouraging. The cells successfully took up the nanoparticles and began manufacturing the protein, releasing it into the surrounding liquid. When the team compared the performance of their new PAS-coated trucks against trucks coated with the traditional PEG, the differences were surprisingly small. Both types of trucks were roughly the same size, measuring between 85 and 120 nanometers in diameter, and they both carried their genetic cargo with similar efficiency, trapping about half of the available instructions inside. They also shared the same electrical charge on their surface, a property that helps them stay stable and avoid clumping together.
Crucially, the study addressed the issue of immune recognition. The team tested whether the new trucks would be mistaken for the old ones by the immune system. They found that antibodies designed to hunt down PEG did not react to the new PAS-coated trucks at all. Conversely, antibodies designed to recognize the natural PAS chain only reacted with the new trucks, not the old PEG ones. This confirmed that the two coatings are chemically distinct and that the new trucks would not trigger the same immune responses that plague the synthetic ones. Furthermore, when they measured how much protein the cells produced, the PAS-coated trucks performed just as well as, and in some cases slightly better than, the PEG-coated versions.
The researchers also looked at the purity of their new materials. The synthetic PEG chains used in current medicines are not uniform; they are a mix of chains of slightly different lengths, like a pile of ropes where some are a few inches longer than others. In contrast, the natural PAS chains the team created are perfectly uniform, with every single chain being exactly the same length. This consistency could be a significant advantage for manufacturing high-quality medicines. The study concludes that these natural peptide coatings are a viable, biodegradable alternative to the synthetic PEG shield. They offer the same protective benefits without the risk of accumulation in the body or the potential for immune reactions, suggesting a path toward safer and more tolerable genetic therapies for the future.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.